Cryoprotective isoliquiritigenin-zein phosphatidylcholine nanoparticles inhibits breast cancer-bone metastasis by targeting JAK-STAT signaling pathways.

MLA

Ganesan, Kumar, et al. “Cryoprotective Isoliquiritigenin-Zein Phosphatidylcholine Nanoparticles Inhibits Breast Cancer-Bone Metastasis by Targeting JAK-STAT Signaling Pathways.” Chemico-Biological Interactions, vol. 396, June 2024, p. 111037. EBSCOhost, https://doi.org/10.1016/j.cbi.2024.111037.

APA

Ganesan, K., Xu, C., Xie, C., Sui, Y., Zheng, C., Gao, F., & Chen, J. (2024). Cryoprotective isoliquiritigenin-zein phosphatidylcholine nanoparticles inhibits breast cancer-bone metastasis by targeting JAK-STAT signaling pathways. Chemico-Biological Interactions, 396, 111037. https://doi.org/10.1016/j.cbi.2024.111037

Chicago

Ganesan, Kumar, Cong Xu, Chunguang Xie, Yue Sui, Chuan Zheng, Fei Gao, and Jianping Chen. 2024. “Cryoprotective Isoliquiritigenin-Zein Phosphatidylcholine Nanoparticles Inhibits Breast Cancer-Bone Metastasis by Targeting JAK-STAT Signaling Pathways.” Chemico-Biological Interactions 396 (June): 111037. doi:10.1016/j.cbi.2024.111037.